UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000038927 |
|---|---|
| Receipt number | R000044325 |
| Scientific Title | Association between Corticotropin-Releasing Hormone peptide expression and cancer progrssion as well as emotion in pancreatic cancer |
| Date of disclosure of the study information | 2019/12/25 |
| Last modified on | 2019/12/19 11:32:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Association between Corticotropin-Releasing Hormone peptide expression and cancer progrssion as well as emotion in pancreatic cancer
Acronym
Association between CRH peptide expression and cancer progrssion as well as emotion in pancreatic cancer
Scientific Title
Association between Corticotropin-Releasing Hormone peptide expression and cancer progrssion as well as emotion in pancreatic cancer
Scientific Title:Acronym
Association between CRH peptide expression and cancer progrssion as well as emotion in pancreatic cancer
Region
| Japan |
Condition
Condition
pancreatic cancer
Classification by specialty
| Hepato-biliary-pancreatic surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Association between CRH peptide expression and cancer progrssion as well as emotion in pancreatic cancer
Basic objectives2
Others
Basic objectives -Others
QOL, Depression
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Association between CRH expression in tumor tissues and recurrence
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1. Possibly resectable of Pancreatic cancer
2. ECOG PS of 0 or 1
3. tolerable function of bone marrow, liver and kidney..
4. Possible oral intake.
5. written informed consent
6. over 20 years old
Key exclusion criteria
1. Pulmonary fibrosis or interstitial pneumonitis
2. Patients expectd R2 resection
3. Patients with synclonous double cancer
4. Active infection
5. HBs Ag positive
6. Patients requiring the administration of flucytosine, phenytoin or warfarin potassium
7. Patients who are pregnant or possibly pregnant.
8.The patient judged to be unsuitable by attending doctor
Target sample size
140
Research contact person
Name of lead principal investigator
| 1st name | Michiaki |
| Middle name | |
| Last name | Unno |
Organization
Tohoku University Graduate School of Medicine
Division name
Department of Surgery
Zip code
980-8575
Address
2-1 seiryo-machi, Aoba-ku, Sendai, Japan
TEL
022-717-7201
m_unno@surg.med.tohoku.ac.jp
Public contact
Name of contact person
| 1st name | Naoko |
| Middle name | SATO |
| Last name | Sato |
Organization
Tohoku University Graduate School of Medicine
Division name
Behavioral Medicine
Zip code
980-8575
Address
2-1 seiryo-machi, Aoba-ku, Sendai, Japan
TEL
022-717-8160
Homepage URL
naoko-s@med.tohoku.ac.jp
Sponsor or person
Institute
Tohoku University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
JSPS KAKENHI Grant
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tohoku University Graduate School of Medicine
Address
2-1, seiryo-machi
Tel
022-717-8007
med-kenkyo@grp.tohoku.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 12 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2019 | Year | 05 | Month | 14 | Day |
Date of IRB
| 2019 | Year | 05 | Month | 30 | Day |
Anticipated trial start date
| 2019 | Year | 12 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 04 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
QOL
Management information
Registered date
| 2019 | Year | 12 | Month | 19 | Day |
Last modified on
| 2019 | Year | 12 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044325
